PKM and neoplasm: Firstly, shikonin reduced the proliferation of LLC and B16 tumor cells and this effect was correlated with its inhibitory effect on tumor cell aerobic glycolysis, Secondly, the effect of shikonin on suppressing tumor cell aerobic glycolysis could be offset by modulating PKM2 level and activity.